Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-073992
Filing Date
2024-06-21
Accepted
2024-06-21 17:15:56
Documents
6
Effectiveness Date
2024-06-21

Document Format Files

Seq Description Document Type Size
1 S-8 tm2417417d1_s8.htm S-8 56319
2 EXHIBIT 5.1 tm2417417d1_ex5-1.htm EX-5.1 6563
3 EXHIBIT 23.1 tm2417417d1_ex23-1.htm EX-23.1 1978
4 EXHIBIT 23.2 tm2417417d1_ex23-2.htm EX-23.2 2100
5 EX-FILING FEES tm2417417d1_ex-filingfees.htm EX-FILING FEES 11006
6 GRAPHIC tm2417417d1_ex5-1img001.jpg GRAPHIC 15242
  Complete submission text file 0001104659-24-073992.txt   100246
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280417 | Film No.: 241061385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)